THERAtRAME
The computed 12-month bankruptcy probability of THERAtRAME is 1.1% (low). The 2024 annual accounts show equity of €775k and a net result of €-1.07M. Its solvency ranks better than 30% of 42 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €775k |
| Net result | €-1.07M |
| Staff (FTE) | 7.2 |
| Better than sector | 30% |
Mixed profile: strong on stability, weaker on profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 35.0% | 53.6% | |
| Net result | €-1.07M | €-16k | |
| Equity | €775k | €644k | |
| Gross operating margin | €7k | €7k | |
| Total assets | €2.22M | €1.71M |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-488k |
| Net profit | €-1.07M |
| Cash flow | €447k |
| Staff costs | €494k |
| Income taxes | €-59k |
| Dividends | - |
| Total assets | €2.22M |
| Equity | €775k |
| Debt | €1.44M |
| of which ≤ 1y | €776k |
| of which > 1y | €653k |
| Working capital | €988k |
| Employees (FTE) | 7.2 |
| 2024 | |
|---|---|
| Current ratio | 2.27 |
| Quick ratio | 2.27 |
| Working capital ratio | 44.6% |
| Solvency | 35.0% |
| Debt / equity | 1.86 |
| Long-term debt ratio | 0.84 |
| Interest coverage | -42.72 |
| Gross margin | - |
| Net margin | - |
| ROA | -48.4% |
| ROE | -138.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.22M |
| Fixed assets | 21/28 | €452k |
| Intangible fixed assets | 21 | €253k |
| Tangible fixed assets | 22/27 | €199k |
| Current assets | 29/58 | €1.76M |
| Amounts receivable within one year | 40/41 | €431k |
| Cash & bank | 54/58 | €1.12M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.22M |
| Equity | 10/15 | €775k |
| Contributions / capital | 10/11 | €2.97M |
| Accumulated profits (losses) | 14 | €-2.20M |
| Amounts payable | 17/49 | €1.44M |
| Amounts payable after one year | 17 | €653k |
| Amounts payable within one year | 42/48 | €776k |
| Trade debts payable within one year | 44 | €270k |
| Income statement | ||
| Gross operating margin | 9900 | €7k |
| Operating result | 9901 | €-2.01M |
| Financial income | 75 | €887k |
| Financial charges | 65 | €11k |
| Result before taxes | 9903 | €-1.13M |
| Income taxes | 67/77 | €-59k |
| Net result for the period | 9904 | €-1.07M |
| Result to be appropriated | 9905 | €-1.07M |
-
JCO Consulting SRLLegal entityDirector· perm. rep.: Jean CombalbertState Gazette act 25086684 (09-07-2025)Current14-04-2025 → present
-
QBIC VENTURE PARTNERS IIILegal entityDirector· perm. rep.: Sara VANDENWIJNGAERTState Gazette act 24065353 (23-04-2024)Current04-09-2023 → present
-
Current03-08-2022 → present
-
NOSHAQ PARTNERSLegal entityDirector· perm. rep.: LIMBOURG Marleen JohannaState Gazette act 22350205 (03-08-2022)Current03-08-2022 → present
-
Current03-08-2022 → present
-
RAPINO ManagementLegal entityDirector· perm. rep.: RAPINO FrancescaState Gazette act 22350205 (03-08-2022)Current03-08-2022 → present
-
Current03-08-2022 → present
-
VENTURE COACHINGLegal entityDirector· perm. rep.: MATTIVI Didier Jean-Marie JosephState Gazette act 22350205 (03-08-2022)Current03-08-2022 → present
-
Current03-08-2022 → present
| NACE primary | 72200 |
| Legal form | Public limited company(014) |
| Incorporation | 23-05-2022 |
| Status | Active |
| Postal code | 4000 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62826D0504/00R002 ProtectedMonument |
Wallonia | 1.4 ha | 1 · 2.3 ha | 48.9 m · 8 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
29-05-2026 Notarial deed · General meeting · Auditor waiver · Capital increase
- Filing: 2026-05-27 · THERAtRAME
- Publication: 2026-05-29 · THERAtRAME
- Notarial deed: 2026-04-21 · THERAtRAME
- General meeting: 2026-04-21 · THERAtRAME
- Auditor waiver · THERAtRAME
- Capital increase: share_type: actions nouvelles sans désignation de valeur nominale, shares_created: 200000 · THERAtRAME
- Share distribution: shares: 50000 · THERAtRAME
- Share distribution: shares: 25000 · THERAtRAME
- Share distribution: shares: 50000 · THERAtRAME
- Share distribution: shares: 75000 · THERAtRAME
- Capital increase: bank_account: BE18 3632 7430 8865 · THERAtRAME
- Power of attorney: purpose: disposer des fonds affectés à la libération de l'augmentation de capital · THERAtRAME
- Auditor report: 2026-04-14 · THERAtRAME
- Share distribution: type: droits de souscription nominatifs (Warrants), shares: 67826, validity: 10 ans, condition: attribution effective par le Conseil d'administration · THERAtRAME
- Statute amendment: article: 5, content: Le capital est fixé à quatre millions quatre cent septante-six mille cinq cent vingt-cinq euros quarante-huit cents (4.476.525,48 €). Il est représenté par neuf cent quatre-vingt-quatre mille deux cent vingt-deux (984.222) actions, sans désignation de valeur nominale, représentant chacune une part égale du capital. · THERAtRAME
- Statute amendment: article: 9.6 §1 (ii), content: les Parties Cédantes peuvent exiger de chacun des (autres) actionnaires ainsi que de tous les détenteurs de droits de souscription d'actions (y compris par conversion) (les Parties obligées) de vendre et de transférer leurs actions et droits dans le cadre de cette transaction proposée (ou de toute autre action nécessaire pour effectuer la transaction concernée) selon les mêmes termes et conditions, tels qu’acceptés par les Parties Cédantes, y compris le prix (étant toutefois entendu que, (i) WALLONIE ENTREPRENDRE, NOSHAQ SPIN-OFFS et NOSHAQ EUROPE 4, GESVAL, QBIC III et FFM ne seront pas liées par une quelconque obligation de non-concurrence qui pourrait être convenue par certains ou tous les autres vendeurs, dans la mesure où cela ne bloque pas la vente des actions et (ii) que les titres donnant droit à des actions seront considérés sur une base "par action, comme si elle était exercée/convertie", en déduisant leur prix d’exercice/conversion par action) (l’Obligation de suite); et · THERAtRAME
- Act object: STATUTS (TRADUCTION, COORDINATION, AUTRES
Technical details
{
"facts": [
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 27-05-2026",
"value": "2026-05-27",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 29/05/2026 - Annexes du Moniteur belge",
"value": "2026-05-29",
"object": null,
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "En vertu d\u2019un acte re\u00E7u le 21 avril 2026 par Benjamin PONCELET, notaire \u00E0 Li\u00E8ge",
"value": "2026-04-21",
"object": "e2",
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "l\u2019assembl\u00E9e g\u00E9n\u00E9rale extraordinaire des actionnaires de la soci\u00E9t\u00E9 anonyme \u00AB THERAtRAME \u00BB ... a pris \u00E0 l\u2019unanimit\u00E9, les d\u00E9cisions suivantes",
"value": "2026-04-21",
"object": null,
"subject": "e1"
},
{
"type": "auditor_waiver",
"quote": "l\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de renoncer \u00E0 \u00E9tablir les rapports vis\u00E9s \u00E0 l\u2019article 7:179 \u00A71er.",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de deux millions d\u2019euros (2.000.000,00 \u20AC) pour le porter de deux millions quatre cent septante-six mille cinq cent vingt-cinq euros quarante-huit cents (2.476.525,48 \u20AC) \u00E0 quatre millions quatre cent septante-six mille cinq cent vingt-cinq euros quarante-huit cents (4.476.525,48 \u20AC) par la cr\u00E9ation de deux cent mille (200.000) actions nouvelles sans d\u00E9signation de valeur nominale, \u00E0 souscrire en num\u00E9raire au prix de dix euros (10 \u20AC) par action",
"value": {
"delta": {
"amount": 2000000.0,
"currency": "EUR"
},
"share_type": "actions nouvelles sans d\u00E9signation de valeur nominale",
"issue_price": {
"amount": 10.0,
"currency": "EUR"
},
"amount_after": {
"amount": 4476525.48,
"currency": "EUR"
},
"amount_before": {
"amount": 2476525.48,
"currency": "EUR"
},
"shares_created": 200000
},
"object": null,
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "Cinquante mille (50.000) actions \u00E0 la soci\u00E9t\u00E9 NOSHAQ EUROPE 4 ... Cinq cent mille euros (500.000,00 \u20AC) en ce qui concerne NOSHAQ EUROPE 4",
"value": {
"amount": {
"amount": 500000.0,
"currency": "EUR"
},
"shares": 50000
},
"object": "e4",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "Vingt-cinq mille (25.000) actions \u00E0 la soci\u00E9t\u00E9 QBIC III FUND ... Deux cent cinquante mille euros (250.000,00 \u20AC) en ce qui concerne QBIC III FUND",
"value": {
"amount": {
"amount": 250000.0,
"currency": "EUR"
},
"shares": 25000
},
"object": "e5",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "Cinquante mille (50.000) actions \u00E0 la soci\u00E9t\u00E9 WALLONIE ENTREPRENDRE ... Cinq cent mille euros (500.000,00 \u20AC), en ce qui concerne WALLONIE ENTREPRENDRE",
"value": {
"amount": {
"amount": 500000.0,
"currency": "EUR"
},
"shares": 50000
},
"object": "e6",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "Septante-cinq mille (75.000) actions \u00E0 ONCOVEST SCA SICAR ... Sept cent cinquante mille euros (750.000,00 \u20AC), en ce qui concerne ONCOVEST SCA SICAR",
"value": {
"amount": {
"amount": 750000.0,
"currency": "EUR"
},
"shares": 75000
},
"object": "e7",
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "Les souscripteurs d\u00E9clarent que les fonds destin\u00E9s \u00E0 la lib\u00E9ration de leurs apports en num\u00E9raire, soit deux millions d\u2019euros (2.000.000 \u20AC), ont \u00E9t\u00E9 d\u00E9pos\u00E9s \u00E0 un compte sp\u00E9cial ouvert au nom de la soci\u00E9t\u00E9 aupr\u00E8s de la banque ING Belgium SA sous le num\u00E9ro BE18 3632 7430 8865.",
"value": {
"amount": {
"amount": 2000000.0,
"currency": "EUR"
},
"bank_account": "BE18 3632 7430 8865"
},
"object": "e9",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e donne pouvoir \u00E0 Madame RAPINO Francesca \u00E0 l\u0027effet de disposer des fonds affect\u00E9s \u00E0 la lib\u00E9ration de l\u0027augmentation de capital.",
"value": {
"purpose": "disposer des fonds affect\u00E9s \u00E0 la lib\u00E9ration de l\u0027augmentation de capital"
},
"object": "e8",
"subject": "e1"
},
{
"type": "auditor_report",
"quote": "du rapport \u00E9tabli par la soci\u00E9t\u00E9 HLB NICOLET \u0026 C\u00B0 ... repr\u00E9sent\u00E9e par Monsieur Jean NICOLET, r\u00E9viseur d\u2019entreprises, en date du 14 avril 2026 2026, sur l\u0027\u00E9mission de droits de souscription (Warrants ESOP)",
"value": "2026-04-14",
"object": "e10",
"subject": "e1"
},
{
"type": "share_distribution",
"quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019\u00E9mettre, \u00E0 titre gratuit, maximum soixante-sept mille huit cent vingt-six (67.826) droits de souscription nominatifs (Warrants) ... Les droits de souscription seront valables pendant dix (10) ans \u00E0 dater de leur \u00E9mission.",
"value": {
"type": "droits de souscription nominatifs (Warrants)",
"shares": 67826,
"validity": "10 ans",
"condition": "attribution effective par le Conseil d\u0027administration"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "l\u2019assembl\u00E9e d\u00E9cide de remplacer l\u2019article 5 des statuts actuels par le texte suivant : \u00AB Le capital est fix\u00E9 \u00E0 quatre millions quatre cent septante-six mille cinq cent vingt-cinq euros quarante-huit cents (4.476.525,48 \u20AC). Il est repr\u00E9sent\u00E9 par neuf cent quatre-vingt-quatre mille deux cent vingt-deux (984.222) actions, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune une part \u00E9gale du capital. \u00BB",
"value": {
"article": "5",
"content": "Le capital est fix\u00E9 \u00E0 quatre millions quatre cent septante-six mille cinq cent vingt-cinq euros quarante-huit cents (4.476.525,48 \u20AC). Il est repr\u00E9sent\u00E9 par neuf cent quatre-vingt-quatre mille deux cent vingt-deux (984.222) actions, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune une part \u00E9gale du capital."
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "L\u2019assembl\u00E9e d\u00E9cide de remplacer l\u2019article 9.6 (Obligation de suite), \u00A71, (ii), par le texte suivant : \u00AB (ii) les Parties C\u00E9dantes peuvent exiger de chacun des (autres) actionnaires ainsi que de tous les d\u00E9tenteurs de droits de souscription d\u0027actions (y compris par conversion) (les Parties oblig\u00E9es) de vendre et de transf\u00E9rer leurs actions et droits dans le cadre de cette transaction propos\u00E9e (ou de toute autre action n\u00E9cessaire pour effectuer la transaction concern\u00E9e) selon les m\u00EAmes termes et conditions, tels qu\u2019accept\u00E9s par les Parties C\u00E9dantes, y compris le prix (\u00E9tant toutefois entendu que, (i) WALLONIE ENTREPRENDRE, NOSHAQ SPIN-OFFS et NOSHAQ EUROPE 4, GESVAL, QBIC III et FFM ne seront pas li\u00E9es par une quelconque obligation de non-concurrence qui pourrait \u00EAtre convenue par certains ou tous les autres vendeurs, dans la mesure o\u00F9 cela ne bloque pas la vente des actions et (ii) que les titres donnant droit \u00E0 des actions seront consid\u00E9r\u00E9s sur une base \u0022par action, comme si elle \u00E9tait exerc\u00E9e/convertie\u0022, en d\u00E9duisant leur prix d\u2019exercice/conversion par action) (l\u2019Obligation de suite); et \u00BB",
"value": {
"article": "9.6 \u00A71 (ii)",
"content": "les Parties C\u00E9dantes peuvent exiger de chacun des (autres) actionnaires ainsi que de tous les d\u00E9tenteurs de droits de souscription d\u0027actions (y compris par conversion) (les Parties oblig\u00E9es) de vendre et de transf\u00E9rer leurs actions et droits dans le cadre de cette transaction propos\u00E9e (ou de toute autre action n\u00E9cessaire pour effectuer la transaction concern\u00E9e) selon les m\u00EAmes termes et conditions, tels qu\u2019accept\u00E9s par les Parties C\u00E9dantes, y compris le prix (\u00E9tant toutefois entendu que, (i) WALLONIE ENTREPRENDRE, NOSHAQ SPIN-OFFS et NOSHAQ EUROPE 4, GESVAL, QBIC III et FFM ne seront pas li\u00E9es par une quelconque obligation de non-concurrence qui pourrait \u00EAtre convenue par certains ou tous les autres vendeurs, dans la mesure o\u00F9 cela ne bloque pas la vente des actions et (ii) que les titres donnant droit \u00E0 des actions seront consid\u00E9r\u00E9s sur une base \u0022par action, comme si elle \u00E9tait exerc\u00E9e/convertie\u0022, en d\u00E9duisant leur prix d\u2019exercice/conversion par action) (l\u2019Obligation de suite); et"
},
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte : STATUTS (TRADUCTION, COORDINATION, AUTRES",
"value": "STATUTS (TRADUCTION, COORDINATION, AUTRES",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 19168,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0786.448.581",
"kind": "company",
"name": "THERAtRAME",
"attrs": {
"seat": "Avenue de l\u0027H\u00F4pital 1, 4000 Li\u00E8ge",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Benjamin PONCELET",
"attrs": {
"firm": "NOTABIS",
"role": "notaire",
"location": "Li\u00E8ge (2e canton)"
}
},
{
"id": "e3",
"kbo": null,
"kind": "org",
"name": "NOTABIS",
"attrs": {
"seat": "4000 Li\u00E8ge, Place de Bronckart, 17",
"legal_form": "SRL"
}
},
{
"id": "e4",
"kbo": null,
"kind": "company",
"name": "NOSHAQ EUROPE 4",
"attrs": {
"role": "actionnaire"
}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "QBIC III FUND",
"attrs": {
"role": "actionnaire"
}
},
{
"id": "e6",
"kbo": null,
"kind": "company",
"name": "WALLONIE ENTREPRENDRE",
"attrs": {
"role": "actionnaire"
}
},
{
"id": "e7",
"kbo": "1036.680.867",
"kind": "company",
"name": "ONCOVEST SCA SICAR",
"attrs": {
"role": "actionnaire",
"seat": "Capellen",
"reg_lux": "B288518",
"commercial_address": "89D Parc d\u0027activit\u00E9s, 8308 Capellen, Grand-Duch\u00E9 de Luxembourg"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "RAPINO Francesca",
"attrs": {
"role": "mandataire"
}
},
{
"id": "e9",
"kbo": null,
"kind": "org",
"name": "ING Belgium SA",
"attrs": {
"role": "banque"
}
},
{
"id": "e10",
"kbo": "0876.193.377",
"kind": "org",
"name": "HLB NICOLET \u0026 C\u00B0",
"attrs": {
"role": "r\u00E9viseur d\u0027entreprises",
"seat": "4910 Theux, Transvaal 63, bte 1"
}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Jean NICOLET",
"attrs": {
"role": "r\u00E9viseur d\u0027entreprises"
}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "MAJOIE J\u00E9rome Jean-Ghislain Hugues",
"attrs": {
"role": "administrateur"
}
},
{
"id": "e13",
"kbo": null,
"kind": "org",
"name": "VENTURE COACHING",
"attrs": {
"role": "administrateur sortant",
"legal_form": "SRL"
}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "MATTIVI Didier",
"attrs": {
"role": "repr\u00E9sentant de VENTURE COACHING"
}
}
]
}22-12-2025 Capital decrease of €3,591,250.52 to €2,476,525.48
- €6.067.776 → €2.476.525,48
Technical details
{
"events": [
{
"kind": "capital_decrease",
"amount": 3591250.52,
"currency": "EUR",
"after_eur": 2476525.48,
"delta_eur": -3591250.52,
"before_eur": 6067776.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-12-16",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de trois millions cinq cent nonante et un mille deux cent cinquante euros cinquante-deux cents (3.591.250,52 \u20AC), pour le porter de six millions soixante-sept mille sept cent septante-six euros (6.067.776,00 \u20AC) \u00E0 deux millions quatre cent septante-six mille cinq cent vingt-cinq euros quarante-huit cents (2.476.525,48 \u20AC)",
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0786.448.581",
"name_full": "THERATRAME",
"legal_form": "SA"
}
}23-10-2025 Capital increase of €3,097,776 to €6,067,776
- €2.970.000 → €6.067.776
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 3097776.0,
"currency": "EUR",
"after_eur": 6067776.0,
"delta_eur": 3097776.0,
"before_eur": 2970000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-10-20",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital \u00E0 concurrence de trois millions nonante-sept mille sept cent septante-six euros (3.097.776,00\u20AC) pour le porter de deux millions neuf cent septante mille euros (2.970.000,00 \u20AC) \u00E0 six millions soixante-sept mille sept cent septante-six euros (6.067.776,00 \u20AC) par l\u2019\u00E9mission de trois cent quatre-vingt-sept mille deux cent vingt-deux (387.222) actions nouvelles \u00E0 souscrire au prix de huit euros (8 \u20AC) par action, et \u00E0 lib\u00E9rer imm\u00E9diatement \u00E0 concurrence de la totalit\u00E9 par les souscripteurs par l\u2019apport d\u2019une cr\u00E9ance d\u00E9tenue par chacun d\u2019eux \u00E0 l\u2019encontre de la soci\u00E9t\u00E9.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0786.448.581",
"name_full": "THERATRAME",
"legal_form": "SA"
}
}09-07-2025 Jean Combalbert appointed as director
- Jean Combalbert, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean Combalbert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "JCO Consulting SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-04-14",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer JCO Consulting SRL, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent M. Jean Combalbert, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 avec effet \u00E0 compter du 14 avril 2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0786.448.581",
"name_full": "THERATRAME",
"legal_form": "SA"
}
}23-04-2024 Sara VANDENWIJNGAERT appointed as director
- Sara VANDENWIJNGAERT, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sara VANDENWIJNGAERT",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0782427932",
"name": "QBIC VENTURE PARTNERS III",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-09-04",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer la soci\u00E9t\u00E9 anonyme QBIC VENTURE PARTNERS III (num\u00E9ro d\u0027entreprise 0782.427.932), ayant son si\u00E8ge situ\u00E9 \u00E0 Hekers 3, 9052 Gent, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 avec effet au 4 septembre 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0786.448.581",
"name_full": "THERATRAME",
"legal_form": "SA"
}
}03-08-2022 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": true,
"object_change": true,
"effective_date": "2022-07-28",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0786.448.581",
"name_full": "THERATRAME",
"legal_form": "SA"
},
"signature_regime": "joint_two",
"special_mandates": [
{
"quote": "L\u0027assembl\u00E9e conf\u00E8re \u00E9galement tous pouvoirs \u00E0 Christoph Michiels, Sander Kevelaerts, Gauthier Davignon, Pierre Luttgens, ou tout autre avocat ou collaborateur du cabinet Deloitte Legal, qui tous, \u00E0 cet effet, \u00E9lisent domicile \u00E0 Luchthaven Brussel Nationaal 1 J, 1930 Zaventem, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u2019\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u2019entreprise en vue d\u2019assurer l\u2019inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
"holder_kbo": null,
"holder_name": "Deloitte Legal",
"scope_categories": [
"KBO",
"tax",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}25-05-2022 Incorporation of a new SNC
Technical details
{
"kind": "oprichting",
"seat": "Avenue de l\u0027H\u00F4pital 1, 4000 Li\u00E8ge",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1979-10-04",
"name": "CLOSE Pierre Jean Marie Andr\u00E9",
"niss": null,
"address": "4031 Li\u00E8ge (Angleur), rue de la Belle-Jardini\u00E8re, 399"
},
"share_class": "capital",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 110000,
"holder_person_name": "CLOSE Pierre Jean Marie Andr\u00E9",
"is_subscriber_only": true,
"n_shares_subscribed": 61000,
"amount_subscribed_eur": 110000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1985-06-02",
"name": "RAPINO Francesca",
"niss": null,
"address": "4000 Li\u00E8ge, Place des Franchises, 2"
},
"share_class": "capital",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 110000,
"holder_person_name": "RAPINO Francesca",
"is_subscriber_only": true,
"n_shares_subscribed": 61000,
"amount_subscribed_eur": 110000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 220000,
"subject_company": {
"kbo": "0786.448.581",
"name_full": "THERATRAME",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2022-05-20",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | THERAtRAME |